SCHEMBL24634591

SCHEMBL24634591

Cc1ccc(Nc2cnccc2C(=O)NCC(O)CO)c(F)c1

nearest known ligand 0.78

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 8/20 0.78
MAP2K2 P36507 1/20 0.78
PRKCZ Q05513 1/20 0.78
IARS2 Q9NSE4 1/20 0.78
PDE10A Q9Y233 1/20 0.47
NUDT1 P36639 1/20 0.42
DHODH Q02127 2/20 0.41
TGFBR1 P36897 6/20 0.41
TGFBR2 P37173 1/20 0.41
KDR P35968 2/20 0.40
ACVR1B P36896 3/20 0.40
ACVRL1 P37023 2/20 0.40
FLT1 P17948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22039304 1.00 MAP2K1 (0.78) MAP2K1MAP2K2PRKCZIARS2PDE10A
SCHEMBL14684301 1.00 MAP2K1 (0.78) MAP2K1MAP2K2PRKCZIARS2PDE10A
Pimasertib SCHEMBL2021184 0.88 MAP2K1 (1.00) MAP2K1MAP2K2PRKCZIARS2PDE10A
Pimasertib SCHEMBL29604438 0.88 MAP2K1 (1.00) MAP2K1MAP2K2PRKCZIARS2PDE10A
Pimasertib SCHEMBL22046269 0.88 MAP2K1 (1.00) MAP2K1MAP2K2PRKCZIARS2PDE10A
Pimasertib SCHEMBL2720659 0.88 MAP2K1 (1.00) MAP2K1MAP2K2PRKCZIARS2PDE10A
Pimasertib SCHEMBL29358435 0.88 MAP2K1 (1.00) MAP2K1MAP2K2PRKCZIARS2PDE10A
Pimasertib SCHEMBL18260054 0.87 MAP2K1 (0.98) MAP2K1MAP2K2PRKCZIARS2PDE10A
Pimasertib SCHEMBL29867955 0.87 MAP2K1 (0.98) MAP2K1MAP2K2PRKCZIARS2PDE10A
SCHEMBL15233262 0.85 MAP2K1 (0.57) MAP2K1MAP2K2PRKCZIARS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022212568-A9 COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM 1BASE PHARMACEUTICALS, LLC (US) 2023-11-16 WO disclosed
WO-2022212568-A1 COMPOUNDS AND COMPOSITIONS FOR MODULATING LIPID METABOLISM 1BASE PHARMACEUTICALS, LLC (US) 2022-10-06 WO disclosed